Metastatic malignant struma ovarii: Two scenarios of the same pathology
Endocrinol Diabetes Nutr. 2017 Feb;64(2):121-122.
doi: 10.1016/j.endinu.2016.09.008.
Epub 2017 Feb 1.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Endocrinología y Nutrición, Complejo Hospitalario de Navarra, Pamplona, Navarra, España. Electronic address: [email protected].
- 2 Servicio de Endocrinología y Nutrición, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
- 3 Servicio de Ginecología y Obstetricia, Complejo Hospitalario de Navarra, Pamplona, Navarra, España.
No abstract available
Publication types
-
Case Reports
-
Comparative Study
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Carcinoma, Papillary / diagnosis
-
Carcinoma, Papillary / drug therapy
-
Carcinoma, Papillary / secondary*
-
Cell Differentiation
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Doxorubicin / administration & dosage
-
Fatal Outcome
-
Female
-
Humans
-
Hysterectomy
-
Iodine Radioisotopes / therapeutic use
-
Liver Neoplasms / drug therapy
-
Liver Neoplasms / secondary*
-
Middle Aged
-
Ovarian Neoplasms / pathology*
-
Ovarian Neoplasms / surgery
-
Peritoneal Neoplasms / drug therapy
-
Peritoneal Neoplasms / secondary*
-
Struma Ovarii / drug therapy
-
Struma Ovarii / secondary*
-
Struma Ovarii / surgery
-
Thyroidectomy
Substances
-
Antineoplastic Agents
-
Iodine Radioisotopes
-
Iodine-131
-
Doxorubicin
-
Cisplatin